Inspire Medical Systems (INSP) Operating Expenses (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Operating Expenses data on file, last reported at $178.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 3.45% year-over-year to $178.0 million; the trailing twelve-month figure through Mar 2026 stood at $733.7 million (up 10.94% YoY), and the FY2025 full-year result was $727.8 million, up 13.06% from the prior year.
• Operating Expenses eased to $178.0 million in Q1 2026, from $186.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $186.9 million in Q4 2025 to a low of $75.4 million in Q1 2022.
• A 5-year average of $147.5 million and a median of $155.2 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 69.58% in 2022 and climbed 3.45% in 2026, its largest moves.
• Tracing INSP's Operating Expenses over 5 years: stood at $116.1 million in 2022, then soared by 33.66% to $155.2 million in 2023, then increased by 10.76% to $171.8 million in 2024, then grew by 8.76% to $186.9 million in 2025, then declined by 4.74% to $178.0 million in 2026.
• Business Quant data shows INSP's Operating Expenses at $178.0 million in Q1 2026, $186.9 million in Q4 2025, and $183.1 million in Q3 2025.